Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

ClinicalTrials.gov ID: NCT00241722

Public ClinicalTrials.gov record NCT00241722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 11:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate Long-Term Safety and Efficacy of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain

Study identification

NCT ID
NCT00241722
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry
Enrollment
805 participants

Conditions and interventions

Interventions

  • Alvimopan Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2005
Primary completion
Jan 31, 2007
Completion
Jan 31, 2007
Last update posted
Aug 29, 2017

2005 – 2007

United States locations

U.S. sites
143
U.S. states
37
U.S. cities
123
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35215
GSK Investigational Site Birmingham Alabama 35242
GSK Investigational Site Birmingham Alabama 35244
GSK Investigational Site Huntsville Alabama 35801
GSK Investigational Site Mobile Alabama 36606
GSK Investigational Site Muscle Shoals Alabama 35662
GSK Investigational Site Northport Alabama 35476
GSK Investigational Site Glendale Arizona 85306
GSK Investigational Site Phoenix Arizona 85023
GSK Investigational Site Phoenix Arizona 85029
GSK Investigational Site Phoenix Arizona 85032
GSK Investigational Site Scottsdale Arizona 85251
GSK Investigational Site Scottsdale Arizona 85258
GSK Investigational Site Sun City Arizona 85351
GSK Investigational Site Tempe Arizona 85282
GSK Investigational Site Tucson Arizona 85712
GSK Investigational Site Tucson Arizona 85741
GSK Investigational Site Hot Springs Arkansas 71913
GSK Investigational Site Little Rock Arkansas 72223
GSK Investigational Site Anaheim California 92801
GSK Investigational Site Anaheim California 92805
GSK Investigational Site Bakersfield California 93311
GSK Investigational Site Beverly Hills California 90211
GSK Investigational Site Buena Park California 90620
GSK Investigational Site Burbank California 91505
GSK Investigational Site Los Gatos California 95032
GSK Investigational Site Orange California 92868
GSK Investigational Site Palm Springs California 92262
GSK Investigational Site Pismo Beach California 93449
GSK Investigational Site San Diego California 92108
GSK Investigational Site San Diego California 92120
GSK Investigational Site San Diego California 92121
GSK Investigational Site Torrance California 90503
GSK Investigational Site Vista California 92083
GSK Investigational Site Stratford Connecticut 6497
GSK Investigational Site Trumbull Connecticut 06611
GSK Investigational Site Brandon Florida 33511
GSK Investigational Site Chiefland Florida 32626
GSK Investigational Site Clearwater Florida 33756
GSK Investigational Site Clearwater Florida 33765
GSK Investigational Site DeLand Florida 32720
GSK Investigational Site Deerfield Beach Florida 33441
GSK Investigational Site Fort Myers Florida 33907
GSK Investigational Site Gainesville Florida 32607
GSK Investigational Site Holly Hill Florida 32117
GSK Investigational Site Hollywood Florida 33021
GSK Investigational Site Jupiter Florida 33458
GSK Investigational Site Miami Florida 33169
GSK Investigational Site Ocala Florida 32607
GSK Investigational Site Ocala Florida 34471
GSK Investigational Site Orlando Florida 32804
GSK Investigational Site Ormond Beach Florida 32174
GSK Investigational Site Saint Cloud Florida 34769
GSK Investigational Site West Palm Beach Florida 33409
GSK Investigational Site Dawsonville Georgia 30534
GSK Investigational Site Marietta Georgia 30066
GSK Investigational Site Stockbridge Georgia 30281
GSK Investigational Site Suwanee Georgia 30024
GSK Investigational Site Boise Idaho 83702
GSK Investigational Site Meridian Idaho 83642
GSK Investigational Site Arlington Heights Illinois 60005
GSK Investigational Site Bloomington Illinois 61701
GSK Investigational Site Chicago Illinois 60610
GSK Investigational Site Rockford Illinois 61107
GSK Investigational Site Elkhart Indiana 46515
GSK Investigational Site Indianapolis Indiana 46250
GSK Investigational Site Louisville Kentucky 40205
GSK Investigational Site Louisville Kentucky 40213
GSK Investigational Site Madisonville Kentucky 42431
GSK Investigational Site Baton Rouge Louisiana 70808
GSK Investigational Site Shreveport Louisiana 71103
GSK Investigational Site Pasadena Maryland 21122
GSK Investigational Site Rockville Maryland 20852
GSK Investigational Site Boston Massachusetts 02115
GSK Investigational Site Brockton Massachusetts 02301
GSK Investigational Site Wellesley Hills Massachusetts 02481
GSK Investigational Site Detroit Michigan 48202
GSK Investigational Site Grand Blanc Michigan 48439
GSK Investigational Site Portage Michigan 49024
GSK Investigational Site Traverse City Michigan 49684
GSK Investigational Site Chaska Minnesota 55318
GSK Investigational Site Olive Branch Mississippi 38654
GSK Investigational Site Manchester Missouri 63021
GSK Investigational Site Nixa Missouri 65714
GSK Investigational Site St Louis Missouri 63108
GSK Investigational Site Missoula Montana 59804
GSK Investigational Site Omaha Nebraska 68114
GSK Investigational Site Henderson Nevada 89015
GSK Investigational Site Las Vegas Nevada 89102
GSK Investigational Site Las Vegas Nevada 89103
GSK Investigational Site Las Vegas Nevada 89119
GSK Investigational Site Dover New Hampshire 03820
GSK Investigational Site Blackwood New Jersey 08012
GSK Investigational Site Elizabeth New Jersey 07202
GSK Investigational Site Albuquerque New Mexico 87102
GSK Investigational Site Lake Success New York 11042
GSK Investigational Site Asheville North Carolina 28801
GSK Investigational Site Charlotte North Carolina 28204
GSK Investigational Site Concord North Carolina 28025
GSK Investigational Site Greensboro North Carolina 27401
GSK Investigational Site Greensboro North Carolina 27403
GSK Investigational Site Hickory North Carolina 28601
GSK Investigational Site Raleigh North Carolina 27607
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Centerville Ohio 45450
GSK Investigational Site Cincinnati Ohio 45219
GSK Investigational Site Cincinnati Ohio 45224
GSK Investigational Site Columbus Ohio 43215
GSK Investigational Site Dayton Ohio 45408
GSK Investigational Site Dayton Ohio 45439
GSK Investigational Site Dayton Ohio 46432
GSK Investigational Site Clinton Oklahoma 73601
GSK Investigational Site Oklahoma City Oklahoma 73112
GSK Investigational Site Medford Oregon 97504
GSK Investigational Site Oregon City Oregon 97045
GSK Investigational Site Portland Oregon 97210
GSK Investigational Site Carnegie Pennsylvania 15106
GSK Investigational Site Pittsburgh Pennsylvania 15243
GSK Investigational Site Reading Pennsylvania 19611
GSK Investigational Site Woonsocket Rhode Island 02895
GSK Investigational Site Chattanooga Tennessee 37403
GSK Investigational Site Clarksville Tennessee 37043
GSK Investigational Site Kingsport Tennessee 37660
GSK Investigational Site Arlington Texas 76017
GSK Investigational Site Brownwood Texas 76801
GSK Investigational Site Dallas Texas 75218
GSK Investigational Site Grand Prairie Texas 75052
GSK Investigational Site Houston Texas 77074
GSK Investigational Site Houston Texas 77090
GSK Investigational Site Lake Jackson Texas 77566
GSK Investigational Site Lancaster Texas 75146
GSK Investigational Site Richardson Texas 75080
GSK Investigational Site San Antonio Texas 78238
GSK Investigational Site Salt Lake City Utah 84106
GSK Investigational Site Salt Lake City Utah 84120
GSK Investigational Site Norfolk Virginia 23502
GSK Investigational Site Richmond Virginia 23294
GSK Investigational Site Virginia Beach Virginia 23452
GSK Investigational Site Bellingham Washington 98226
GSK Investigational Site Edmonds Washington 98026
GSK Investigational Site Spokane Washington 99204
GSK Investigational Site Tacoma Washington 98405
GSK Investigational Site Charleston West Virginia 25304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 84 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00241722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 29, 2017 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00241722 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →